
AppliedXL turns public data into timely, actionable signals so teams can respond before news breaks. It combines domain-specific AI analysts with editorial verification to detect, verify, and explain…

AppliedXL turns public data into timely, actionable signals so teams can respond before news breaks. It combines domain-specific AI analysts with editorial verification to detect, verify, and explain…
What they do: B2B SaaS platform that converts public data into early, auditable signals using ML plus human editorial verification
Headquarters: Brooklyn, New York
Founders / leadership: Francesco Marconi (Co‑founder & CEO), Erin Riglin (Co‑founder & CTO)
Founded: 2020
Typical customers: Equity researchers, pharma/biotech teams, exchanges, newsrooms and data platforms
Funding signal: Seed funding raised (notable seed round $1.5M in April 2021); multiple seed investors listed
Event/signal detection from public records (notably clinical trials and regulatory data) for investment, pharma, exchanges, and newsroom use cases.
2020
Software Development
$1.5M
Seed funding announced April 22, 2021 to develop editorial algorithms and ML tools for real-time data tracking
5999999 USD
Most recent funding date listed in profile data
“Multiple early investors including Hearst Ventures, Fc Centripetal, Montage Ventures and others”
| Company |
|---|
Job Description: Data Journalist, Biotech & Life Sciences
Reports to: Head of GenAI Content
Location: New York or Philadelphia (Hybrid)
Please include a cover letter outlining your interest in the role and how your skills align with AppliedXL and send to support@appliedxl.com.
About AppliedXL
AppliedXL is redefining how information powers decisions in the age of AI. As more work flows through machines first, data must be structured, contextual, and trusted. We turn raw information into verified, machine-readable signals that help analysts and AI systems detect what’s changing, before it becomes news.
Starting with biotech, life sciences, and healthcare, our platform surfaces early risks and opportunities weeks ahead of disclosure. Our mission is to deliver news before it becomes news, building the standard for structured intelligence that powers high-stakes decisions across finance, healthcare, and beyond.
By joining AppliedXL, you’ll help shape the trusted signals that humans and machines rely on to see ahead.
The Role
This role sits at the point where data, biotech expertise, and AI reasoning meet. You’ll practice analytical storytelling for decision-makers, translating scientific and regulatory signals into insights that help investors and biopharma teams understand what’s shifting and why it matters.
Your work will blend data exploration, editorial judgment, and AI-assisted analysis. You’ll uncover patterns in public datasets, decide what is genuinely newsworthy, and turn those findings into clear, concise explanations that highlight risk, opportunity, and strategic impact.
You will collaborate closely with the Head of GenAI Content to define how humans and AI work together to detect emerging signals and explain them in concise, high-impact formats. Over time, you will take increased ownership of editorial pipelines, signal quality, and content accuracy across feeds and reports.
This role suits someone who enjoys turning complex clinical and regulatory data into sharp, insightful stories for informed readers.
What You’ll Do
Detect & Understand
Interpret, Explain & Write
Guide AI Reasoning
Integrate & Scale
What We’re Looking For
Salary Range: $75,000–$90,000
Please include a cover letter outlining your interest in the role and how your skills align with AppliedXL and send to support@appliedxl.com.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
4,700+
New This Week